The long term objective of this project is to understand in a more detailed sense the mechanism of action of cGMP in eukaryotic cells. Specifically it will be the goals of this study to delineate the biochemical mechanism of cGMP-induced relaxation of vascular smooth muscle in the hope that this will increase our understanding of vascular smooth muscle function. Using the recent findings on the physiological actions of cGMP derivatives on Ca2+ metabolism in smooth muscle as a starting point, the effects of cGMP and agents which raise cGMP levels on the Ca2+ regulated enzymes myosin light chain kinase and phosphorylase kinase, will be studied. An attempt will be made to correlate the effects of cGMP on tension and Ca2+ regulated enzyme activity in order to probe the effects of cGMP on Ca2+ metabolism. In addition, the effects of specific cGMP-dependent phosphorylation on Ca2+ accumulation in crude, partially purified, and purified membrane fractions from vascular smooth muscle will be studied. The correlation of changes in Ca2+ uptake by these structures with Ca2+ regulated enzyme activity should provide key insights into the mechanism of action of cGMP. And finally, the purification and identification of specific cGMP-protein kinase substrate(s) and its (their) roles(s) in Ca2+ metabolism will be studied. By understanding the biochemical mechanism of action of cGMP in normal smooth muscle physiology, predictions and hypotheses can be tested on what role this system has in vascular abnormalities which occur in pathological situations such as essential hypertension. Furthermore, an understanding of the actions of cGMP in smooth muscle will aid in our knowledge of its role in other systems where the nucleotide and its receptors are prominent, i.e., brain, heart, and secretory tissues.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL034646-04
Application #
3347770
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1985-01-01
Project End
1990-03-31
Budget Start
1988-04-01
Budget End
1989-03-31
Support Year
4
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of South Alabama
Department
Type
Schools of Medicine
DUNS #
City
Mobile
State
AL
Country
United States
Zip Code
36688
Libby, Peter (2003) Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol 91:3A-6A
Anderson, P G; Boerth, N J; Liu, M et al. (2000) Cyclic GMP-dependent protein kinase expression in coronary arterial smooth muscle in response to balloon catheter injury. Arterioscler Thromb Vasc Biol 20:2192-7
Komalavilas, P; Shah, P K; Jo, H et al. (1999) Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells. J Biol Chem 274:34301-9
Dey, N B; Boerth, N J; Murphy-Ullrich, J E et al. (1998) Cyclic GMP-dependent protein kinase inhibits osteopontin and thrombospondin production in rat aortic smooth muscle cells. Circ Res 82:139-46
Soff, G A; Cornwell, T L; Cundiff, D L et al. (1997) Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP. J Clin Invest 100:2580-7
Boerth, N J; Dey, N B; Cornwell, T L et al. (1997) Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. J Vasc Res 34:245-59
Komalavilas, P; Lincoln, T M (1996) Phosphorylation of the inositol 1,4,5-trisphosphate receptor. Cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta. J Biol Chem 271:21933-8
Murphy-Ullrich, J E; Pallero, M A; Boerth, N et al. (1996) Cyclic GMP-dependent protein kinase is required for thrombospondin and tenascin mediated focal adhesion disassembly. J Cell Sci 109 ( Pt 10):2499-508
Qian, Y; Chao, D S; Santillano, D R et al. (1996) cGMP-dependent protein kinase in dorsal root ganglion: relationship with nitric oxide synthase and nociceptive neurons. J Neurosci 16:3130-8
Bergh, C M; Brophy, C M; Dransfield, D T et al. (1995) Impaired cyclic nucleotide-dependent vasorelaxation in human umbilical artery smooth muscle. Am J Physiol 268:H202-12

Showing the most recent 10 out of 37 publications